BioXcel Therapeutics (BTAI) Total Debt (2018 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Total Debt of $100.3 million for Q1 2026, down 4.96% year-over-year from $105.5 million in Q1 2025, and down 8.49% quarter-over-quarter from $109.6 million in Q4 2025.
BioXcel Therapeutics (BTAI) Total Debt (2018 - 2026) Analysis & Trends
BioXcel Therapeutics' Total Debt history runs 9 years deep, the most recent figure standing at $100.3 million for Q1 2026.
- In Q1 2026, Total Debt fell 4.96% year-over-year to $100.3 million; the TTM figure through Mar 2026 stood at $100.3 million (down 4.96% YoY), while the FY2025 annual figure was $109.6 million, up 6.91% from the prior year.
- Total Debt for Q1 2026 stood at $100.3 million, down from $109.6 million in the prior quarter.
- The five-year high for Total Debt was $109.6 million in Q4 2025, with the low at $56000.0 in Q1 2022.
- The 5-year median for Total Debt is $100.6 million (2023), against an average of $93.2 million.
- The sharpest annual moves came in 2023 and 2026: Total Debt jumped 170332.14% in 2023, then dropped 4.96% in 2026.
- BioXcel Therapeutics' Total Debt stood at $93.5 million in 2022, then climbed by 7.62% to $100.6 million in 2023, then grew by 1.9% to $102.5 million in 2024, then increased by 6.91% to $109.6 million in 2025, then decreased by 8.49% to $100.3 million in 2026.
- Business Quant data shows BTAI's Total Debt at $100.3 million in Q1 2026, $109.6 million in Q4 2025, and $109.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 | 104.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.45 Mn |
| Mar 31, 2026 | 100.29 Mn |
| Dec 31, 2025 | 109.59 Mn |
| Sep 30, 2025 | 109.13 Mn |
| Jun 30, 2025 | 108.69 Mn |
| Mar 31, 2025 | 105.53 Mn |
| Dec 31, 2024 | 102.51 Mn |
| Sep 30, 2024 | 104.44 Mn |
| Jun 30, 2024 | 103.01 Mn |
| Mar 31, 2024 | 101.63 Mn |
| Dec 31, 2023 | 100.60 Mn |
| Sep 30, 2023 | 99.82 Mn |
| Jun 30, 2023 | 97.70 Mn |
| Mar 31, 2023 | 95.44 Mn |
| Dec 31, 2022 | 93.47 Mn |
| Sep 30, 2022 | 91.96 Mn |
| Jun 30, 2022 | 61.37 Mn |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 154,000.00 |